Animal models of heart failure

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 3, 1999, Pages 403-409

  Arnolda, L F ^a,b   Llewellyn Smith, I J ^b   Minson, J B ^b  

^a Cardiovascular Neurosciences Group   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Doxorubicin cardiomyopathy; Myocardial infarction; Pacing induced heart failure; Renin; Sympathetic nervous system; Vasopressin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN; RENIN; VASOPRESSIN;

ANIMAL MODEL; CARDIOMEGALY; CONFERENCE PAPER; EDEMA; EXERCISE TOLERANCE; HEART FAILURE; HEART INFARCTION; HEART OUTPUT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE PACING; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0033067414     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00735.x     Document Type: Conference Paper

References (48)

1. 1. Parameshwar MM, Richardson A, Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract 1992; 42: 287-9.
2. 2. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol 1985; 55: 3A-8A.
3. 3. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993; 126: 632-40.
4. 4. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989; 80: 299-305.
5. 5. Harris P. Evolution and the cardiac patient. Cardiovasc Res 1983; 17: 437-45.
6. 6. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-55.
7. 7. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
8. 8. Davis JO. Physiology of congestive heart failure. In: The handbook of physiology, Circulation III, American Physiological Society, Washington DC: 1965; 2071-122.
9. 9. Watkins L Jr, Burton JA, Haber E, Cant JR, Smith FW, Barger AC. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 1976; 57: 1606-17.
10. 10. Hufnagel CA, Roe BB, Barger AC. A technique for producing pulmonary artery stenosis. Surgery 1951; 29: 77.
11. 11. Yankopoulos NA, Davis JO, McFarland JA, Holman J. Physiologic changes during chronic congestive heart failure in dogs with tricuspid insufficiency and pulmonic stenosis. Circ Res 1959; 7: 950.
12. 12. Majid PA, Sharma B, Taylor SH. Phentolamine for vasodilator treatment of severe heart-failure. Lancet 1971; 2: 719-24.
13. 13. Bing OH, Brooks WW, Robinson KG et al. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 1995; 27: 383-96.
14. 14. Spielman WS, Davis JO, Gotshall RW. Hypersecretion of renin in dogs with a chronic aortic-caval fistula and high-output heart failure. Proc Soc Exp Biol Med 1973; 143: 479-82.
15. 15. Flaim SF, Minteer WJ, Nellis SH, Clark DP. Chronic arteriovenous shunt: evaluation of a model for heart failure in rat. Am J Physiol 1979; 236: H698-704.
16. 16. Carlyle PF, Cohn JN. A nonsurgical canine model of chronic left ventricular myocardial dysfunction. Am J Physiol 1983; 244: H769-74.
17. 17. Arnolda L, McGrath BP, Johnston CI. Systemic and regional effects of vasopressin and angiotensin in acute left ventricular failure. Am J Physiol 1991; 260: H499-H506.
18. 18. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32: 302-14.
19. 19. Jaenke RS, Deprez-DeCampeneere D, Trouet A. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit. Cancer-Res 1980; 40: 3530-6.
20. 20. Arnolda LF, McGrath BP, Cocks M, Sumithran E, Johnston CI. Adriamycin cardiomyopathy in the rabbit - an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc Res 1985; 19: 378-82.
21. 21. Arnolda LF, McGrath BP, Cocks M, Johnston CI. Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit. J Clin Invest 1986; 78: 674-8.
22. 22. McGrath BP, Sano N, Way D. Shift in the baroreflex-renal noradrenaline spillover curve during the development of congestive heart failure in the rabbit. Clin Exp Pharmacol Physiol 1990; 17: 303-7.
23. 23. Woodcock EA, Arnolda LF, McGrath BP. Ventricular beta-adrenoceptors in Adriamycin-induced cardiomyopathy in the rabbit. J Mol Cell Cardiol 1988; 20: 771-8.
24. 24. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensititivity to agonist response. Circulation 1986; 74: 1290-302.
25. 25. McGrath BP, Jover BF, Trigg L, Arnolda LF. Adriamycin induced cardiomyopathic heart failure in the rabbit. In: Kawaii C, Abelman W (Eds). Pathogenesis of Myocarditis and Cardiomyopathy. Tokyo: University of Tokyo Press, 1988; 121-33.
26. 26. Unverferth DV, Croskery RW, Leier CV et al. Canine cobalt cardiomyopathy: a model for the study of heart failure. Am J Vet Res 1983; 44: 989-95.
27. 27. Czarneck CM. Animal models of drug-induced cardiomyopathy. Comp Biochem Physiol C 1984; 79: 9-14.
28. 28. Hood WB, McCarthy B, Lown B. Myocardial infarction following coronary ligation in dogs: haemodynamic effects of isoprotorenol and acetylstrophantidin. Cir Res 1967; 21: 191-9.
29. 29. Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 1978; 90: 57-70.
30. 30. Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503-12.
31. 31. Hodsman GP, Kohzuki M, Howes LG, Sumithran E, Tsunoda K, Johnston CI. Neurohumoral responses to chronic myocardial infarction in rats. Circulation 1988; 78: 376-81.
32. 32. Tsunoda K, Hodsman GP, Sumithran E, Johnston CI. Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res 1986; 59: 256-61.
33. 33. Teerlink JR, Loffler BM, Hess P, Maire JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Circulation 1994; 90: 2510-8.
34. 34. Feng QP, Carlsson S, Thoren P, Hedner T. Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat. Acta Physiol Scand 1994; 150: 259-66.
35. 35. Howes LG, Hodsman GP, Maccarrone C, Kohzuki M, Johnston CI. Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels in a rat model of left ventricular failure. J Cardiovasc Pharmacol 1989; 13: 348-52.
36. 36. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985; 57: 84-95.
37. 37. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985; 72: 406-12.
38. 38. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988; 319: 80-6.
39. 39. Mulinari RA, Gavras I, Wang YX, Franco R, Gavras H. Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction. Circulation 1990; 81: 308-11.
40. 40. Musch TI, Moore RL, Leathers DJ, Bruno A, Zelis R. Endurance training in rats with chronic heart failure induced by myocardial infarction. Circulation 1986; 74: 431-41.
41. 41. Arnolda L, Brosnan J, Rajagopalan B, Radda GK. Skeletal muscle metabolism in heart failure in the rat. Am J Physiol 1991; 261: H434-H442.
42. 42. Arnolda L, Conway M, Dolecki M et al. Skeletal Muscle Metabolism in Heart Failure. A 31P magnetic resonance study of leg muscle. Clinical Science 1990; 79: 583-9.
43. 43. Coleman HN 3rd, Taylor RR, Pool PE et al. Congestive heart failure following chronic tachycardia. Am Heart J 1971; 81: 790-8.
44. 44. Riegger AJ, Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci 1982; 62: 465-9.
45. 45. Fitzpatrick MA, Espiner EA, Ikram H, Nicholls MG, Bagshaw P, Yandle TG. ANP infusion in the treatment of heart failure and comparison with ACE inhibition. J Cardiovasc Pharmacol 1990; 15: 536-43.
46. 46. Chow E, Woodward JC, Farrar DJ. Rapid ventricular pacing in pigs: an experimental model of congestive heart failure. Am J Physiol 1990; 258: H1603-5.
47. 47. Wilson JR, Douglas P, Hickey WF et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 1987; 75: 857-67.
48. 48. Abelmann WH, Wagner RI, Bajusz E. Serial haemodynamic observations in hereditary cardiomyopathy in the Syrian hamster. In: Bajusz E, Rona G (Eds). Cardiomyopathies. Baltimore: University Park Press, 1973; 509-18.